Iopromide Explained

Iopromide is an iodinated contrast medium for X-ray imaging. It is marketed under the name Ultravist which is produced by Bayer Healthcare. It is a low osmolar, non-ionic contrast agent for intravascular use; i.e., it is injected into blood vessels.[1]

It is commonly used in radiographic studies such as intravenous urograms, brain computer tomography (CT) and CT pulmonary angiograms (CTPAs).

Medical uses

The radiocontrast agent is given intravenously in computed tomography (CT) scans, angiography and excretory urography.[2]

Contraindications

Iopromide use is contraindicated in myelography, cerebral ventriculography and cisternography procedures. It is also contraindicated in those with hyperthyroidism, or with known allergy to the drug.[3]

Iopromide is also contraindicated in children with prolonged fasting, fluid restriction, on laxative, or dehydration as it can cause renal failure.[3]

External links

Notes and References

  1. Book: Austria-Codex. Haberfeld H . Ultravist 300 mg J/ml-Infusionsflaschen. Österreichischer Apothekerverlag. Vienna. 2020. German.
  2. Web site: Prescribing information - Ultravist . Bayer Healthcare pharmaceuticals . https://web.archive.org/web/20210410001722/https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021425s028lbl.pdf . 10 April 2021.
  3. Web site: PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION ULTRAVIST® Iopromide Injection . Bayer Healthcare Pharmaceuticals . 16 April 2024 . https://web.archive.org/web/20211027140756/https://www.bayer.com/sites/default/files/2020-11/ultravist-pm-en.pdf . 27 October 2021.